Home » Newsletters » BioWorld Asia

BioWorld Asia

Sep. 30, 1998

View Archived Issues

Council Of State Freezes Transgenic Plant Ruling

Synaptic Weight Theory Regains Respect Through New Saturation Experiment

British Biotech Managers Step Down At Meeting

Irish BioVentures Hoping To Bridge Research, Finance

Biota's Influenza Drug Shows Positive Results

Core Group Losses Up; On Plan, Company Says

D-Pharm Buys Lipid 'Tag' Rights From Oregon Firm

Chiroscience Group Aims At Profitability In 2001

Metabolic Pharmaceuticals Works On Anti-Fat Drug

Biovector, Biomira Sign $16M Deal For Lymphoma Vaccine

Trinity Biotech Acquires FDA-OK'd Cardiac Test

Visible Genetics Study Tests HIV Genotyping

Oxford Reports Losses Up; Deals Promise More Cash

A Message To BioWorld Subscribers About Copyright Law

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...